MedTrace Logo

BlueSync Field Evaluation

NCT03518658 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 257

Last updated 2021-05-06

Study results available
· View outcomes & findings →

Summary

The purpose of this field evaluation is to collect and evaluate information related to CareLink transmission compliance as well as patient perceived benefit of BlueSync™ and the health care provider perception of the value of BlueSync™ and satisfaction with BlueSync™.

Conditions

  • Bradycardia

Interventions

OTHER

Evaluation Group

Patient receiving exposure to the MyCareLink Heart App during device pairing

OTHER

Control Group (Historical)

Patients receiving exposure to the CareLink Monitor 2490 (Excluding wireless model 2490C). The patients' data will be extracted from Medtronic de-identified CareLink™ database.

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Khaldoun Trajki, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-02
Primary Completion
2019-12-29
Completion
2019-12-29

Countries

  • United States
  • France
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03518658 on ClinicalTrials.gov